Board meeting on 04 November 2026 to consider unaudited results for September quarter
Chemiesynth (Vapi) Ltd has told BSE that its Board will meet on Wednesday, 04 November 2026 at 02:00 PM.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Wednesday, 04 November 2026 at 02:00 PM
- Agenda
- Un-Audited Financial Results for the quarter and half year ended 30 September 2026, with the limited review report
- Trading Window
- closed from Thursday, 01 October 2026; opens 48 hours after the results are declared
What the company has said
Chemiesynth (Vapi) Ltd has informed BSE that a meeting of its Board of Directors is scheduled to be held on Wednesday, 04 November 2026 at the registered office of the company at 02:00 PM.
Agenda of the meeting
- To discuss, consider, approve and take on record the Un-Audited Financial Results of the Company for the quarter and half year ended 30 September 2026, along with the limited review report.
- Any other items with the permission of the Chair and Majority of Directors.
The words to note are discuss, consider, approve and take on record. The results are still to be placed before the Board; this notice does not contain any financial figures.
Trading window
- The trading window was closed from Thursday, 01 October 2026.
- It shall open after 48 hours of declaration of the Results.
What this means for a reader
This is a routine advance notice of a board meeting. It tells you when the company's September quarter numbers are expected to come before the Board, and therefore roughly when they are likely to be published. The results date itself is not given here; the notice only fixes the meeting date of 04 November 2026.
The limited review report mentioned is the auditor's review of the unaudited quarterly and half-yearly results, which is shared together with the results.
Until the results are declared, the trading window remains closed for designated persons covered by the company's insider trading code, as stated in the notice.
What to watch for
- The Un-Audited Financial Results for the quarter and half year ended 30 September 2026, once approved and shared.
- The limited review report that accompanies them.
This notice carries no revenue, profit, margin or order-book figures, so it does not by itself say anything about how the company performed in the September 2026 quarter.
Also from Chemiesynth (Vapi)
Board approves allotment of 1,00,00,000 unlisted NCRPS on private placement basis
28 Oct 2026
Board approves allotment of 1,00,00,000 unlisted NCRPS under First Tranche
28 Oct 2026
Board meeting on 28 October 2026 to consider allotment of unlisted NCRPS on private placement
23 Oct 2026
More numbers
- Time after results declaration when trading window opens48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.